title: Experience with Vi typhoid capsular polysaccharide vaccine in the U.K.
abstract: Adult volunteers were immunised with a single dose of typhoid Vi capsular polysaccharide vaccine. After immunisation, 96% of the 103 subjects seroconverted and 94% had antibody levels above the protective threshold. Systemic reactions were uncommon, local reactions were mild and transient.
authors.affiliation: Mérieux U.K. Ltd, Maidenhead, Berkshire, U.K.
authors.forename: W S
authors.initials: WS
authors.lastname: Arnold
authors.forename: A W
authors.initials: AW
authors.lastname: Harcus
authors.forename: J
authors.initials: J
authors.lastname: St Clair Roberts
authors.forename: A E
authors.initials: AE
authors.lastname: Ward
mesh_terms: D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D006801:Humans; D011135:Polysaccharides, Bacterial / Q000009:adverse effects; D012485:Salmonella typhi / Q000276:immunology*; D014435:Typhoid Fever / Q000276:immunology / Q000517:prevention & control; D014611:Vaccination / Q000009:adverse effects
chemical_list: D000907:Antibodies, Bacterial; D011135:Polysaccharides, Bacterial; C054154:capsular polysaccharide, Salmonella